Author Question: The mother of a school-aged child voices concern to the nurse about her 4-year-old son continuing to ... (Read 82 times)

tnt_battle

  • Hero Member
  • *****
  • Posts: 556
The mother of a school-aged child voices concern to the nurse about her 4-year-old son continuing to wet the bed at night. What information should be provided by the nurse?
 
  A) It is very uncommon for a child of this age to have bedwetting issues.
  B) Did any of your other children have this problem?
  C) While this is distressing it is not completely uncommon but interventions are not normally introduced until age 6.
  D) You will need to strictly restrict intake in the afternoon and evenings to prevent this from happening.

Question 2

Which one of the following teaching activities would most likely be implemented by an occupational health nurse?
 
  A) Safe sex
  B) Infection control
  C) Cardiopulmonary resuscitation
  D) The need for immunizations



Bigfoot1984

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

Ans: C

Answer to Question 2

Ans: C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

Oliver Wendell Holmes is credited with introducing the words "anesthesia" and "anesthetic" into the English language in 1846.

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library